Aardvark Therapeutics is a company that specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders. It offers ARD-101, an oral investigational drug that operates within the digestive tract by activating bitter taste receptors (TAS2Rs) and stimulating the local release of satiety hormones.